Crossroads of Philadelphia, PA (N Broad St)
2307 North Broad Street
Philadelphia, PA 19132
Call Center Open 24/7/365
Same-day and Virtual Appointments Available
- Center Offerings Care Coordination, Hepatitis C Treatment
- Accepted Insurances Commercial, Medicaid, Medicare, Medicare Advantage, TRICARE, VA CCN
We are dedicated to providing exceptional addiction treatment services in Philadelphia – North Broad Street. Our center specializes in helping individuals overcome opioid addiction through evidence-based treatments. Our professional team, including doctors, nurse practitioners and other healthcare providers, works together to ensure every patient receives the highest quality of care. As a leading addiction treatment center in Philadelphia – North Broad Street, we focus on making recovery accessible and effective for everyone.
About Our Opioid Addiction Treatment Center in Philadelphia – North Broad Street
Since our inception in 2005, Crossroads has been at the forefront of treating patients with opioid use disorder. Located in the heart of Philadelphia, our North Broad Street facility offers a welcoming environment to support patients through every step of their recovery journey.
Our approach combines medication-assisted treatment (MAT) to provide the most effective treatment plans tailored to each individual’s needs, helping them build a foundation for long-term recovery.
Treatment Services We Offer in Philadelphia – North Broad Street
Buprenorphine (Rx): The buprenorphine program at Crossroads offers an alternative treatment option for opioid addiction. Buprenorphine helps manage withdrawal symptoms and reduce cravings. Our experienced medical staff will work with you to develop a personalized treatment plan that includes regular monitoring.
Buprenorphine (SUBLOCADE®): Sublocade is an extended-release formulation of buprenorphine, a partial opioid agonist. It helps reduce cravings and withdrawal symptoms while providing a ceiling effect that lowers the risk of overdose. It is administered as a subcutaneous injection once a month.
Buprenorphine (BRIXADI®): Similar to Sublocade, this formulation of buprenorphine is designed for long-acting use to support recovery from opioid addiction. It is typically administered as a subcutaneous injection, with dosing frequency varying based on the specific formulation (weekly, biweekly, and monthly).
Naltrexone (VIVITROL®): Vivitrol is an extended-release injectable form of naltrexone. It is used to prevent relapse in individuals who have already detoxified from opioids. Naltrexone is an opioid antagonist, meaning it blocks the effects of opioids and reduces cravings. It is given as an intramuscular injection once a month.
Why Choose Crossroads?
Our approach to addiction treatment is comprehensive, combining medication and support services to address the aspects of opioid addiction. Our dedicated professionals work together to ensure each patient receives individualized care tailored to their unique needs.
We strive to create a welcoming and inclusive environment where patients feel supported and empowered. Opting for Crossroads means selecting a companion in your recovery journey who will accompany you every step and furnish the tools and support essential for achieving long-term success.